ProShares Ultra NASDAQ Biotechnology
26 hedge funds and large institutions have $22.9M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.
Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
3
Closed
8
Calls
$5.02M
Puts
$3.93M
Net Calls
+$1.09M
Net Calls Change
+$2.19M